Galmed Pharmaceuticals Ltd. buy Truist Financial Co.
Start price
07.11.25
/
50%
€6.40
Target price
07.11.26
€80.60
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 07.11.26. The prediction end date can be changed by Truist_Financial_Co_ at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical (NYSE:GMED) was upgraded by analysts at Truist Financial Corporation from a "hold" rating to a "buy" rating. They now have a $93.00 price target on the stock, up previously from $65.00.
Ratings data for GMED provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
18.11.25
18.11.25
€90.58
18.11.26
18.11.26
-
19.09.24
19.09.24
